))
Management Strategies for Opioid Use Disorder: Nonpharmacologic and Pharmacologic Approaches
Manage episode 334941535 series 3286928
Conteúdo fornecido por Clinical Care Options. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Clinical Care Options ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
In this episode, Michael Weaver, MD, DFASAM, provides information on both nonpharmacologic and pharmacologic treatment options for patients with opioid use disorder. Listeners will gain an understanding of the available counseling programs and medications for opioid use disorder—methadone, buprenorphine, and naltrexone—including the patient scenarios for which each may be most appropriate. In addition, Dr Weaver emphasizes that substance use disorder is a chronic condition and that optimal treatment involves a multimodal approach.
Presenter:
Michael Weaver, MD, DFASAM
Professor
Department of Psychiatry and Behavioral Sciences
Medical Director
Center for Neurobehavioral Research on Addiction
McGovern Medical School
University of Texas Health Science Center at Houston
Houston, Texas
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see
https://bit.ly/3mgrfb9
for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.
Provided by Clinical Care Options, LLC and in partnership with the American Academy of Physical Medicine and Rehabilitation, Practicing Clinicians Exchange, and ProCE.
Link to full program:
https://bit.ly/3mcDHsi
35 episódios
Compartilhar
